DDAVP infusion in haemophilia A carriers: Different behaviour of plasma factor VIII and von Willebrand factor

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 5, 1996, Pages 549-553

  Casonato, A ^a,b   Dannhauser, D ^a   Pontara, E ^a   Bertomoro, A ^a   Orazi, B ^a   Santarossa, L ^a   Zerbinati, P ^a   Girolami, A ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

DDAVP; Factor VIII; Haemophilia A; Haemophilia A carrier; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; VON WILLEBRAND FACTOR;

ARTICLE; CLINICAL ARTICLE; FEMALE; HEMOPHILIA; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029792230     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199607000-00006     Document Type: Article

References (22)

1. Peake IR, Lillicrap DP, Boulyjenkov V, et al. Report of a joint WHO/WFH meeting on the control of haemophilia: carrier detection and prenatal diagnosis. Blood Coag Fibrinol 1993; 4: 313-344.
2. Hoyer LW, Hemophilia A. New Engl J Med 1994; 330: 38-47.
3. Jedlicka P, Greer S, Millar DS, et al. Improved carrier detection of haemophilia A using novel RFLPs at the DXS115 (767) locus. Hum Genet 1990; 85: 315-318.
4. Tuddenham EGD, Goldman E, McGraw A, Kernoff PBA. Haemophilia A: carrier detection and prenatal diagnosis by linkage analysis using DNA polymorphism. J Clin Path 1987; 40: 971-977.
5. Akhemeteli MA, Aledort LM, Alexaniants S. Methods for the detection of haemophilia carriers: a memorandum. Bulletin of the World Health Organization 1977; 55: 675-702.
6. Zimmerman TS, Ratnoff O, Littell AS. Detection carriers of classic hemophilia using an immunologic assay for antihemophilic factor (factor VIII). J Clin Invest 1971; 50: 255-258.
7. Lillicrap D, Holden JJA, Giles AR, White BN, Ontario Haemophilia Study Group. Carrier detection strategy in haemophilia A: the benefits of combined DNA marker analysis and coagulation testing in sporadic haemophilic families. Br J Haematol 1988; 70: 321-326.
8. Kazazian HH. The molecular basis of haemophilia A and the present status of carrier and antenatal diagnosis of the disease. Thromb Haemost 1993; 70: 60-62.
9. Lyon MF. Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Gen 1962; 14: 244-254.
10. Graham JB, Rizza CR, Chediak J, et al. Carrier detection in hemophilia A: a cooperative international study. I. The carrier phenotype. Blood 1986; 67: 1554-1559.
11. Casonato A, Fabris F, Vicariotto M, Girolami A. The evaluation of factor VIII antigen by means of a simple slide test. Am J Clin Path 1985; 29: 309-316.
12. Girolami A, Molaro G, Lazzarin M, Scarpa R, Brunetti A. A new congenital haemorrhagic condition due to the presence of abnormal factor X (factor X Friuli); study for a large kindred. Br J Haematol 1970; 19: 179-192.
13. Casonato A, Pontara E, Zerbinati P, Girolami A. DDAVP infusion: a possible useful tool in the diagnosis of haemophilia A carrier state. Blood Coag Fibrinol 1991; 2: 679-680.
14. Tuddenham EGD, Cooper DN, Gitschier J, et al. Haemophilia A: database of nucleotide substitutions, deletion, insertions, and rearrangements of the factor VIII gene. Nucleic Acids Res 1991; 19: 4821-4833.
15. Higuchi M, Kazazian HH Jr, Kasch L, et al. Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene. Proc Natl Acad Sci USA 1991; 88: 7405-7409.
16. Gitschier J, Wood WI, Goralka TM, et al. Characterization of the human factor VIII gene. Nature 1984; 312: 326-330.
17. Toole JJ, Knopf JL, Wozney JM, et al. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 1984; 312: 342-347.
18. Moodie P, Liddell MB, Peake IR, Bloom AL. Carrier detection in 50 haemophilia A kindred by means of three intragenic and two extragenic restriction fragment length polymorphisms. Br J Haem 1988; 70: 77-84.
19. Mannucci P. Arginine vasopressin: a new pharmacological approach to the management of haemophilia A and von Willebrand's disease. Lancet 1977; i: 869-872.
20. Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large biologically potent von Willebrand factor multimers. Cell 1986; 46: 185-190.
21. Wion KL, Kelly D, Summerfield JA, Tuddenham EGD, Lawn RM. Distribution of factor-VIII messenger-RNA and antigen in human liver and other tissues. Nature 1986; 317: 726-729.
22. Cattaneo M. Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma FVIII is not secondary to the increase of plasma von Willebrand factor. Br J Haematol 1994; 86: 333-337.